Bio Pharma Dive
OCTOBER 11, 2023
Once the specialty of a few select drugmakers, CRISPR gene editing is now an essential technology for a growing group of biotechs, many led by former students of the field's pioneering scientists.
Pharmaceutical Technology
OCTOBER 11, 2023
Biomarin and CSL Behring’s haemophilia gene therapies have boosted innovation in the field, but assessing their cost effectiveness is less than straightforward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 11, 2023
The finding from the study of its diabetes drug, which Novo didn’t detail, could help the company in its competition with rival drugmaker Eli Lilly.
Pharmaceutical Technology
OCTOBER 11, 2023
GlobalData analyst Wafaa Hasan discusses key topics around cybersecurity for the pharmaceutical industry.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
OCTOBER 11, 2023
The once high-flying biotech is cutting staff for the second time in a year and delaying some research to save cash.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 11, 2023
Deep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer’s disease, the most common form of dementia.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 11, 2023
The advancements in space technology have given hope to the healthcare industry. An amalgamation of the two can provide high-quality surgical care to patients around the world without any geographic barriers, eventually leading to easy access, said Dr.
Pharmaceutical Technology
OCTOBER 11, 2023
SparX’s monoclonal antibody was used to develop the Claudin 18.2 tumour-specific antigen targeting CAR-iNKT cell therapy.
Rethinking Clinical Trials
OCTOBER 11, 2023
Keith Marsolo, PhD In this Friday’s PCT Grand Rounds, Keith Marsolo of Duke University will present “Incorporating Social Determinants of Health Into PCORnet.” The Grand Rounds session will be held on Friday, October 13, 2023, at 1:00 pm eastern. Marsolo is an associate professor of population health sciences at Duke University and a cochair of the NIH Pragmatic Trials Collaboratory’s Electronic Health Records Core Working Group.
Pharmaceutical Technology
OCTOBER 11, 2023
Gritgen Therapeutics has launched operations at its commercial GMP facility in Suzhou Industrial Park, China.
Pharma Times
OCTOBER 11, 2023
The deal gives Kyowa access to a therapy for early-onset metachromatic leukodystrophy - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 11, 2023
The collaboration aims to boost open innovation hub SakuLab-Tsukaba at Astellas’ Tsukuba Research Centre.
Pharma Times
OCTOBER 11, 2023
Eligible patients in Scotland will now have access to Nubeqa and Stivarga - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 11, 2023
MinervaX is currently conducting Phase II trials of the prophylactic maternal vaccine against group B streptococcus bacterial infections.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Fierce Pharma
OCTOBER 11, 2023
For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate. | For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate.
Pharmaceutical Technology
OCTOBER 11, 2023
Microbiome mapping technology company Kanvas Biosciences has announced the acquisition of assets from California-based Federation Bio, bringing with it two active therapeutics programmes.
Rethinking Clinical Trials
OCTOBER 11, 2023
Speakers Speaker: David M. Murray, PhD NIH Associate Director for Prevention and Director, NIH Office of Disease Prevention Moderator: Jonathan C. Moyer, PhD Statistician, NIH Office of Disease Prevention Slides Keywords Implementation; Study design; Hybrid; Clustered; DECIPHeR Key Points People often contest that hybrid designs are not as rigorous as they should be.
Pharmaceutical Technology
OCTOBER 11, 2023
Agomab Therapeutics has secured €94.9m ($100m) in its Series C funding round to advance the development of its fibrosis-focused pipeline.
BioSpace
OCTOBER 11, 2023
Following the recommendations of an independent Data Monitoring Committee, Novo Nordisk has halted a Phase III kidney outcomes study of semaglutide ahead of schedule due to strong efficacy signals.
Pharmaceutical Technology
OCTOBER 11, 2023
Topline results from an ongoing Phase IIa study with SLS009 are expected by the end of the year.
Fierce Pharma
OCTOBER 11, 2023
Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a generic version of the EpiPen allergy relief m | Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a generic version of the EpiPen allergy relief medicine.
Pharmaceutical Technology
OCTOBER 11, 2023
BioMap has entered into a strategic alliance with Sanofi to co-develop AI modules and expedite drug discovery for biotherapeutics.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
OCTOBER 11, 2023
Economist Impact’s Future of Health Europe Summit: Day One Mike.
Pharmaceutical Technology
OCTOBER 11, 2023
Cellipont Bioservices has signed an agreement with Diakonos Oncology to develop DOC1021, a cell therapy to treat glioblastoma multiforme.
Fierce Pharma
OCTOBER 11, 2023
That didn't take long. | Just two weeks after Biogen completed its buyout of Reata Pharmaceuticals, the combined company is trimming its staff. Reata staffers who worked in roles that are already covered at Biogen are losing their jobs.
pharmaphorum
OCTOBER 11, 2023
Eversana acquires pharmaphorum owner Healthware Group Phil.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
OCTOBER 11, 2023
From Statera Biopharma and Sorrento Therapeutics to Aceragen and Infinity Pharmaceuticals, 2023 has seen a record high 28 bankruptcies in the biotech space so far. Here’s why.
Fierce Pharma
OCTOBER 11, 2023
Mallinckrodt has essentially walked back its promise to pay $1.7 billion in an opioid settlement thanks to the company's second bankruptcy in just two years. | Mallinckrodt has essentially walked back its promise to pay $1.7 billion in an opioid settlement thanks to the company's second bankruptcy in just two years.
pharmaphorum
OCTOBER 11, 2023
Faron’s Clever-1 drug shows promise in blood cancers Phil.
Fierce Pharma
OCTOBER 11, 2023
In the race to develop nonsteroidal topical treatments for autoimmune skin conditions, Dermavant is charging toward the finish line—again. | Dermavant has presented evidence that Vtama provides immediate and long-term relief from the severe itch condition pruritus, the most prevalent symptom of atopic dermatitis. The trial results bolster Dermavant's effort to win a label expansion for the drug.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
355 
Let's personalize your content